Elekta A b Aktie
4,56EUR | 0,13EUR | 3,03% |
WKN: 896279 / ISIN: SE0000163628
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 4 100 | 4 342 | 4 826 | 4 390 | 4 641 |
Umsatz pro Mitarbeiter in Mio. EUR | 3,56 | 3,17 | 3,01 | 3,84 | 3,90 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 15 565 | 13 247 | 12 880 | 14 375 | 13 958 |
Summe Anlagevermögen | 17 470 | 14 435 | 14 608 | 16 397 | 18 022 |
Summe Aktiva | 28 411 | 24 844 | 26 718 | 30 123 | 32 398 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 9 358 | 6 238 | 5 695 | 6 668 | 7 248 |
Summe Fremdkapital | 20 298 | 16 647 | 17 802 | 20 390 | 21 619 |
Summe Eigenkapital | 8 113 | 8 197 | 8 916 | 9 733 | 10 779 |
Summe Passiva | 28 411 | 24 844 | 26 718 | 30 123 | 32 398 |
Adresse
Hagaplan 4, 113 68 Stockholm | |
Internet | http://www.elekta.com |
Management
Anna Conneryd Lundgren
Chief People Officer & Executive Vice President |
Birgitta Stymne Göransson
Independent Director |
Caroline Leksell Cooke
Senior Vice President & Head-Neuro Solutions |
Cecilia Wikström
Independent Director |
Gustaf Sverker Littorin
Executive Vice President |
Habib Nehme
Chief Commercial Officer |
Jan Joel Aron Secher
Independent Director |
John Lapré
President-Brachy & Neuro Solutions |
Jonas Bolander
President & Chief Executive Officer |
Kevin Brown
Global Vice President-Scientific Research |
Laurent Leksell
Chairman |
Maurits Wolleswinkel
Chief Product Officer |
Peter Nyquist
Head-Investor Relations |
Susanna Francke Rodau
SVP & Head-Business Line Neuro Solutions |
Tobias Hägglöv
Chief Financial Officer |
Tomas Eliasson
Independent Director |
Volker Wetekam
Independent Director |
Wolfgang Reim
Independent Director |